Brightside Medication Treatment

Brixadi® Treatments in Illinois and Ohio

Newly FDA-approved, Brixadi® is one of the most customizable opioid addiction treatments on the market, providing immediate relief for withdrawal and supporting your recovery.
doctor administering a Brixadi injection

What is Brixadi® Extended-Release Injection Treatment?

Like Sublocade®, Brixadi® is a buprenorphine extended-release injection for subcutaneous administration. It’s designed to treat individuals suffering from moderate to severe opioid use disorder. Brixadi® was approved by the FDA in 2023 as an alternative treatment to other single-dose buprenorphine treatments. Like Suboxone® and Sublocade®, Brixadi® reduces withdrawal symptoms, the likelihood of relapse, and the cravings associated with OUD.

Buprenorphine interacts with the same neuroreceptors in the brain that opioids bind with. It does a better job of binding with neuroreceptors than opioids do, so it blocks the pathways and prevents the abused opioids from targeting them. Additionally, buprenorphine does not provide euphoria the same way opioids do, so there’s no risk of trading one addiction for another.

Ready To Start Treatment?

The Benefits of Brixadi® Medication-Assisted Treatment

One of the main differences between Brixadi® and other buprenorphine treatments is its wide range of available single-dose options. This allows patients a customized treatment experience suited to their needs and lifestyles. Like other injectable buprenorphine treatments, injections can last either a week or month versus hours with oral medication.

Weekly or Monthly Doses

Brixadi® comes in weekly and monthly doses. Depending on your needs, your doctor may place you on weekly doses if you feel cravings are returning near the end of a monthly dose. The variability in dosing also means your Brixadi® treatments can be adjusted to suit your tapering needs as your treatment progresses.

Different Strengths Available

If you struggle with higher doses of injectable buprenorphine treatments, Brixadi® may provide relief.Brixadi® offers doses in various strengths to allow patients of all tolerance levels to receive the treatments they need.

Various Injection Sites

With other buprenorphine treatments, you may experience soreness of the injection site after repeated doses. Brixadi® solves this issue by maintaining effectiveness from multiple recommended injection sites. It can be administered in the buttock, thigh, abdomen, or upper arm (after the first four doses).

Uninterrupted Treatment

Brixadi® works the same way as other buprenorphine injection treatments. This means that individuals who have already initiated treatment with other injectable or oral buprenorphine medication can easily switch to Brixadi® with little difficulty.

Need Support?

Start Your Treatment Journey Today

Our compassionate experts are here to help you determine if Brixadi® is right for you. Contact Brightside Recovery today to begin your journey toward sustainable recovery.
doctor providing telehealth addiction treatment
Telehealth at Brightside

Get Treatment from Home

Ready to take the first step toward recovery? Brightside uses telehealth to ensure everyone can access life-saving addiction treatment no matter where they are. Schedule your virtual visit today!

Contact Us Online or Call Us Today

Other Medication-Assisted Treatment Options

In addition to Brixadi®, Brightside Recovery offers other medications to help curb opioid and alcohol addiction.
woman taking Suboxone prescription with a glass of water

Suboxone

Suboxone® combines buprenorphine and naloxone to reduce withdrawal symptoms while protecting against misuse.
doctor administering a Sublocade injection

Sublocade

Buprenorphine acts as a partial agonist, activating some opioid receptors in the brain to alleviate withdrawal symptoms and cravings.
doctor placing a bandage on a patient after administering a Vivitrol injection

Vivitrol

Naltrexone is a monthly injectable medication that blocks all effects of illicit opioids, helping patients stay in treatment.